Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Glioblastoma 21Brain Neoplasms 15Central Nervous System Neoplasms 14Astrocytoma 9Glioma 7Oligodendroglioma 5Medulloblastoma 4Neoplasms 3Lymphoma 3Gliosarcoma 3Recurrence 2Melanoma 2Lymphoma, AIDS-Related 2Leukemia, Myeloid, Acute 2Uveal Melanoma 1Spinal Cord Neoplasms 1Solid Tumor 1Optic Nerve Glioma 1Newly Diagnosed High Grade Glioma 1Neuroectodermal Tumors 1Lung Neoplasms 1Intraocular Lymphoma 1Familial ependymoma 1Ependymoma 1Drug-Related Side Effects and Adverse Reactions 1Cognition Disorders 1Carcinoma, Non-Small-Cell Lung 1Camurati-Engelmann Syndrome 1Adenocarcinoma, Bronchiolo-Alveolar 1Adenocarcinoma of Lung 1

Interventions

Cytarabine 272Cyclophosphamide 136fludarabine phosphate 127Azacitidine 117Peripheral Blood Stem Cell Transplantation 95Busulfan 93Filgrastim 80Decitabine 79fludarabine 78Mycophenolic Acid 78Idarubicin 76Etoposide 76Whole-Body Irradiation 75Daunorubicin 72Tacrolimus 71Cyclosporine 64Methotrexate 62Mitoxantrone 57Clofarabine 55Antilymphocyte Serum 55Granulocyte Colony-Stimulating Factor 51Gemtuzumab 50Melphalan 49venetoclax 48Radiotherapy 30sargramostim 28Injections 25Bortezomib 25thymoglobulin 24aldesleukin 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Leukemia, Myeloid, Acute × Lomustine × Clear all
NCT00590837 2014-04-02

LAM-SA 2007

University Hospital, Bordeaux

Phase 3 Completed
459 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

NCT00480064 2007-05-30

Lomustine and Intermediate Dose Cytarabine in Older Patients With AML

French Innovative Leukemia Organisation

Phase 3 Completed
360 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡